Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schwabe-Wenex is a pharmaceutical company specializing in the distribution and marketing of high-quality phytopharmaceuticals, primarily serving the Hungarian and regional European markets. As a strategic partner of the Dr. Willmar Schwabe Group, the company focuses on evidence-based herbal medicines derived from standardized plant extracts. Its product portfolio includes leading brands such as Tebokan for cognitive health and Umckaloabo for respiratory infections. The company plays a critical role in bridging German herbal research with local healthcare needs, providing therapeutic solutions for neurology, psychiatry, and internal medicine. Schwabe-Wenex is recognized for its commitment to Phytoneering, a philosophy that combines the potential of nature with modern scientific research and technology. The company ensures that its herbal products meet rigorous pharmaceutical standards for safety and efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schwabe-Wenex.